DNage

About:

DNage engages in the discovery and development of products for aging diseases caused by DNA damage.

Twitter/X: dnage_bv

Top Investors: EQT Life Sciences, Inventages Venture Capital Investment Inc.

Description:

DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH).

Total Funding Amount:

$1.94M

Headquarters Location:

Leiden, Zuid-Holland, The Netherlands

Founded Date:

2004-01-01

Contact Email:

info(AT)dnage.nl

Founders:

Number of Employees:

1-10

Last Funding Date:

2005-04-13

IPO Status:

Private

Industries: